Zdrowie i gospodarka · 12/12/2000

FDA Proposes Revision to Requirements for Licensed Anti-Human Globulin and Blood Grouping Reagents

The Food and Drug Administration (FDA) is proposing to relax the sterility requirements for licensed Anti-Human Globulin (AHG) and Blood Grouping Reagents (BGR), citing that these requirements are not necessary for the products to be safe, pure, and potent.